Association of High LDH and Low Glucose Levels in Pleural Space with HER2 Expression in Non-Small Cell Lung Cancer |
Ziaian, Bijan
(Department of Surgery, Namazi Hospital)
Saberi, Ali (Department of Surgery, Namazi Hospital) Ghayyoumi, Mohammad Ali (Department of Internal Medicine, School of Medicine, Faghihi Hospital) Safaei, Akbar (Department of Pathology, Faghihi Hospital) Ghaderi, Abbas (Cancer Proteomics and Biomarkers Lab, Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences) Mojtahedi, Zahra (Cancer Proteomics and Biomarkers Lab, Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences) |
1 | Zinner RG, Glisson BS, Fossella FV, et al (2004). Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpressing disease. Lung Cancer, 44, 99-110. DOI ScienceOn |
2 | Panagiotou I, Georgiannos SN, Tsiambas E, et al (2012). Impact of HER2 and PTEN simultaneous deregulation in non-small cell lung carcinoma: correlation with biological behavior. Asian Pac J Cancer Prev, 13, 6311-8. DOI ScienceOn |
3 | Limthongkul S (1989). The pathogenesis of low pleural fluid glucose in acidotic malignant pleural effusions. J Med Assoc Thai, 72, 492-7. |
4 | Masoompour SM, Yarmohammadi H, Rezaianzadeh A, Lankarani KB (2011). Cancer incidence in southern Iran, 1998-2002: results of population-based cancer registry. Cancer Epidemiol, 35, 42-7. DOI ScienceOn |
5 | Mojtahedi Z, Safaei A, Yousefi Z, Ghaderi A (2011). Immunoproteomics of HER2-positive and HER2-negative breast cancer patients with positive lymph nodes. OMICS, 15, 409-18. DOI ScienceOn |
6 | Pirker R, Minar W (2010). Chemotherapy of advanced non-small cell lung cancer. Front Radiat Ther Oncol, 42, 157-63. |
7 | Sanchez-Armengol A, Rodriguez-Panadero F (1993). Survival and talc pleurodesis in metastatic pleural carcinoma, revisited. Report of 125 cases. Chest, 104, 1482-5. DOI ScienceOn |
8 | Xia Q, Zhu Z, Wang J, et al (2012). Expression and association of HER2 with prognosis in early-stage (T1-T2N0M0) nonsmall cell lung cancer. Tumour Biol, 33, 1719-25. DOI |
9 | Zahir ST, Mirtalebi M (2012). Survival of patients with lung cancer, Yazd, Iran. Asian Pac J Cancer Prev, 13, 4387-91. DOI ScienceOn |
10 | Zhao YH, Zhou M, Liu H, et al (2009). Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth. Oncogene, 28, 3689-701. DOI ScienceOn |
11 | Ghayumi SMA, Aghasadeghi K, Doroudchi M, Ghaderi A (2006). Determination of soluble HER-2/neu (sher-2/neu) in iranian patients with lung cancer. Iran J Immunol, 3, 61-5. |
12 | Bielsa S, Salud A, Martinez M, et al (2008). Prognostic significance of pleural fluid data in patients with malignant effusion. Eur J Intern Med, 19, 334-9. DOI ScienceOn |
13 | Bollig-Fischer A, Dewey TG, Ethier SP (2011). Oncogene activation induces metabolic transformation resulting in insulin-independence in human breast cancer cells. PLoS One, 6, 17959. DOI ScienceOn |
14 | Ernam D, Atalay F, Hasanoglu HC, Kaplan O (2005). Role of biochemical tests in the diagnosis of exudative pleural effusions. Clin Biochem, 38, 19-23. DOI ScienceOn |
15 | Hirsch FR, Varella-Garcia M, Franklin WA, et al (2002b). Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas. Br J Cancer, 86, 1449-56. DOI ScienceOn |
16 | Harris LN, Liotcheva V, Broadwater G, et al (2001). Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapy. J Clin Oncol, 19, 1698-706. DOI |
17 | Heffner JE, Klein JS (2008). Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc, 83, 235-50. DOI |
18 | Hirsch FR, Franklin WA, Bunn PA (2002a). What is the role of HER-2/neu and trastuzumab (Herceptin) in lung cancer? Lung Cancer, 36, 263-4. DOI ScienceOn |